Semaglutide Not Associated with Increased Risk of Eye Disorders, 19 August 2025, The use of semaglutide medicines and risk of non-arteritic anterior ischemic optic neuropathy (NAION), 27 June 2025, WHO, PRAC concludes eye condition NAION is a very rare side effect of semaglutide medicines Ozempic, Rybelsus and Wegovy, 06 June 2025, European Medicine Agency, Kai-Yang Chen, Hoi-Chun Chan, Chi-Ming Chan, does semaglutide increase the risk of non-arteritic anterior ischemic optic neuropathy
Semaglutide is not recommended for use in patients with type 1 diabetes or diabetic ketoacidosis
Most patients live completely normal lives without a gallbladder, and surgery often eliminates recurring abdominal pain caused by gallstones
It usually means the concentration and the syringe are mismatched